AU7053100A - Flint analog compounds and formulations thereof - Google Patents
Flint analog compounds and formulations thereofInfo
- Publication number
- AU7053100A AU7053100A AU70531/00A AU7053100A AU7053100A AU 7053100 A AU7053100 A AU 7053100A AU 70531/00 A AU70531/00 A AU 70531/00A AU 7053100 A AU7053100 A AU 7053100A AU 7053100 A AU7053100 A AU 7053100A
- Authority
- AU
- Australia
- Prior art keywords
- formulations
- analog compounds
- flint analog
- flint
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15343399P | 1999-09-10 | 1999-09-10 | |
US60153433 | 1999-09-10 | ||
PCT/US2000/020806 WO2001018202A2 (en) | 1999-09-10 | 2000-08-31 | Flint analog compounds and formulations thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7053100A true AU7053100A (en) | 2001-04-10 |
Family
ID=22547206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU70531/00A Abandoned AU7053100A (en) | 1999-09-10 | 2000-08-31 | Flint analog compounds and formulations thereof |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1214411A2 (en) |
AU (1) | AU7053100A (en) |
WO (1) | WO2001018202A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7285267B2 (en) | 1997-01-14 | 2007-10-23 | Human Genome Sciences, Inc. | Tumor necrosis factor receptors 6α & 6β |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1247567A (en) * | 1997-01-14 | 2000-03-15 | 人体基因组科学有限公司 | Tumor necrosis factor receptor alfa 6 and receptor beta 6 |
EP1165780A2 (en) * | 1999-03-30 | 2002-01-02 | Eli Lilly And Company | Flint polypeptide analogs |
-
2000
- 2000-08-31 WO PCT/US2000/020806 patent/WO2001018202A2/en not_active Application Discontinuation
- 2000-08-31 EP EP00959164A patent/EP1214411A2/en not_active Withdrawn
- 2000-08-31 AU AU70531/00A patent/AU7053100A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001018202A2 (en) | 2001-03-15 |
EP1214411A2 (en) | 2002-06-19 |
WO2001018202A3 (en) | 2001-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6310000A (en) | Aerosol formulations | |
AU3731600A (en) | Composition and structures made therefrom | |
AUPQ419099A0 (en) | Novel compositions and methods | |
AU7490200A (en) | New and improved formulation for paclitaxel | |
AP9901623A0 (en) | Pharmaceutical formulations comprising amoxocyllin and clavulanate | |
AU3192700A (en) | Medicinal compositions | |
AU5326100A (en) | Pharmaceutical compositions and methods for use | |
AU2005300A (en) | Medicinal compositions | |
AU1887401A (en) | Medicinal composition | |
AU4017500A (en) | Novel formulations comprising lipid-regulating agents | |
AU2184099A (en) | Insecticidal compositions and insecticidal methods | |
AU1403501A (en) | Novel composition and use | |
AUPQ147699A0 (en) | Sunscreen formulations | |
AU6715600A (en) | Pharmaceutical formulations | |
AU4834200A (en) | Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof | |
AU1152601A (en) | Compositions and their use | |
AU4977300A (en) | Pharmaceutical formulations | |
AU1385801A (en) | Pharmaceutical formulations | |
AU6891800A (en) | Flint analog compounds and formulations thereof | |
AU1053501A (en) | Polyazanaphthalene compound and medicinal use thereof | |
AU4543500A (en) | Pharmaceutical compositions and uses | |
AU7681498A (en) | Pharmaceutical composition and use thereof | |
AU7053000A (en) | Flint compounds and formulations thereof | |
AU7053100A (en) | Flint analog compounds and formulations thereof | |
AU5979300A (en) | Angiopoietin-6 and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |